Signaturefd, LLC Beyond Spring Inc. Transaction History

Signaturefd, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$1.68 - $5.01 $95 - $285	-57 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$4.02 - $16.84 $1,527 - $6,399	-380 Reduced 86.96%	57 $0
Q3 2021 Oct 28, 2021	BUY	$9.26 - $31.31 $2,407 - $8,140	260 Added 146.89%	437 $7,000
Q2 2021 Jul 26, 2021	BUY	$9.37 - $12.12 $1,658 - $2,145	177 New	177 $2,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $67M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.